Ignite Creation Date:
2025-12-26 @ 11:07 AM
Ignite Modification Date:
2026-02-28 @ 3:49 AM
Study NCT ID:
NCT05544812
Status:
UNKNOWN
Last Update Posted:
2022-09-21
First Post:
2022-09-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Small-sample, Real-world Study of Sintilimab Plus Bevacizumab/Cetuximab Plus XELOX Regimen for Conversion Therapy in Patients With Advanced Colorectal Cancer
Sponsor:
Xijing Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-02
First Submit QC Date:
None
Study First Post Date:
2022-09-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-18
Last Update Post Date:
2022-09-21
Last Update Post Date Type:
ACTUAL